Systemic Lupus Erythematosus

You have full text access to this OnlineOpen article

Combined oral contraceptive use and the risk of systemic lupus erythematosus

  1. Marie-odile Bernier1,*,
  2. Yann Mikaeloff2,4,
  3. Marie Hudson3,
  4. Samy SuissA3,†

Article first published online: 30 MAR 2009

DOI: 10.1002/art.24398

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 61, Issue 4, pages 476–481, 15 April 2009

Additional Information

How to Cite

Bernier, M.-o., Mikaeloff, Y., Hudson, M. and SuissA, S. (2009), Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis & Rheumatism, 61: 476–481. doi: 10.1002/art.24398

Author Information

  1. 1

    McGill Pharmacoepidemiology Research Unit, McGill University, Montreal, Quebec, Canada

  2. 2

    McGill Pharmacoepidemiology Research Unit, McGill University, Montreal, Quebec, Canada

  3. 3

    McGill Pharmacoepidemiology Research Unit, McGill University, and SMBD Jewish General Hospital, Montreal, Quebec, Canada

  4. 4

    INSERM U822 and Assistance Publique Hôpitaux de Paris, Bicêtre University Hospital, Le Kremlin Bicêtre, France

  1. †

    Dr. Suissa has received consultancies and funding for other projects from Organon and Schering.

*Centre for Clinical Epidemiology, SMBD Jewish General Hospital, 3755 Cote Ste Catherine Road, Montreal, Québec, Canada H3T 1E2

Publication History

  1. Issue published online: 30 MAR 2009
  2. Article first published online: 30 MAR 2009
  3. Manuscript Accepted: 5 JAN 2009
  4. Manuscript Received: 24 JUL 2008

Funded by

  • Canadian Institutes of Health Research
  • Canadian Foundation for Innovation
  • Distinguished Investigator Award from the Canadian Institutes of Health Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (81K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Karen H. Costenbader, Steffen Gay, Marta E. Alarcón-Riquelme, Luca Iaccarino, Andrea Doria, Genes, epigenetic regulation and environmental factors: Which is the most relevant in developing autoimmune diseases?, Autoimmunity Reviews, 2012, 11, 8, 604

    CrossRef

  2. 2
    Aisha Lateef, Michelle Petri, Hormone replacement and contraceptive therapy in autoimmune diseases, Journal of Autoimmunity, 2012, 38, 2-3, J170

    CrossRef

  3. 3
    Grant C. Hughes, Progesterone and autoimmune disease, Autoimmunity Reviews, 2012, 11, 6-7, A502

    CrossRef

  4. 4
    Monika Østensen, Connective tissue diseases: Contraception counseling in SLE—an often forgotten duty?, Nature Reviews Rheumatology, 2011, 7, 6, 315

    CrossRef

  5. 5
    M. Ludwig, Hormonelle Kontrazeption, Der Gynäkologe, 2011, 44, 1, 23

    CrossRef

  6. 6
    Rujuan Dai, S. Ansar Ahmed, MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases, Translational Research, 2011, 157, 4, 163

    CrossRef

  7. 7
    Emese Kiss, Csaba György Kiss, Gyula Poór, Szisztémás autoimmun betegségek és terhesség, Orvosi Hetilap, 2011, 152, 43, 1715

    CrossRef

  8. 8
    David Serfaty, Contraception, 2011,

    CrossRef

  9. 9
    Robert G. Lahita, Systemic Lupus Erythematosus, 2011,

    CrossRef

  10. 10
    Xavier Juanola Roura, Valeria Ríos Rodríguez, Diana de la Fuente de Dios, Drugs employed during pregnancy and contraceptive methods in rheumatic disease. New evidence, Reumatología Clínica (English Edition), 2010, 6, 1, 43

    CrossRef

  11. 11
    Xavier Juanola Roura, Valeria Ríos Rodríguez, Diana de la Fuente de Dios, Fármacos durante el embarazo y métodos contraceptivos en enfermedades reumáticas. Nuevas aportaciones, Reumatología Clínica, 2010, 6, 1, 43

    CrossRef

  12. 12
    Roni Idan, Steven D. Hajdu, Nancy Agmon-Levin, Yehuda Shoenfeld, Hormonal therapy in a patient with ovarian agenesis and possible SLE: a choice to be made, Clinical Rheumatology, 2010,

    CrossRef

  13. 13
    Cristina Fortes, Lupus erythematosus. Are residential insecticides exposure the missing link?, Medical Hypotheses, 2010, 75, 6, 590

    CrossRef

  14. 14
    Megan E.B. Clowse, Managing contraception and pregnancy in the rheumatologic diseases, Best Practice & Research Clinical Rheumatology, 2010, 24, 3, 373

    CrossRef

  15. 15
    Evelyne Vinet, Jennifer Lee, Christian Pineau, Ann E Clarke, Sasha Bernatsky, Oral contraceptives and risk of systemic lupus erythematosus, International Journal of Clinical Rheumatology, 2010, 5, 2, 169

    CrossRef

  16. 16
    M. Ostensen, A. Brucato, H. Carp, C. Chambers, R. J. E. M. Dolhain, A. Doria, F. Forger, C. Gordon, S. Hahn, M. Khamashta, M. D. Lockshin, M. Matucci-Cerinic, P. Meroni, J. L. Nelson, A. Parke, M. Petri, L. Raio, G. Ruiz-Irastorza, C. A. Silva, A. Tincani, P. M. Villiger, D. Wunder, M. Cutolo, Pregnancy and reproduction in autoimmune rheumatic diseases, Rheumatology, 2010, 50, 4, 657

    CrossRef

  17. 17
    K. Colangelo, S. Haig, A. Bonner, C. Zelenietz, J. Pope, Self-reported flaring varies during the menstrual cycle in systemic lupus erythematosus compared with rheumatoid arthritis and fibromyalgia, Rheumatology, 2010, 50, 4, 703

    CrossRef

  18. 18
    Maurizio Cutolo, Renata Brizzolara, Fabiola Atzeni, Silvia Capellino, Rainer H. Straub, Pier Carlo Sarzi Puttini, The immunomodulatory effects of estrogens, Annals of the New York Academy of Sciences, 2010, 1193, 1
    Direct Link:
  19. 19
    Andrea T. Borchers, Stanley M. Naguwa, Carl L. Keen, M. Eric Gershwin, The implications of autoimmunity and pregnancy, Journal of Autoimmunity, 2010, 34, 3, J287

    CrossRef

  20. 20
    Chi Chiu Mok, Connective tissue diseases: Is combined oral contraceptive use linked to SLE incidence?, Nature Reviews Rheumatology, 2009, 5, 7, 360

    CrossRef

  21. 21
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2009, 18, 11
    Direct Link:
View Full Article (HTML) Get PDF (81K)